Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516265 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
ElectronicAdd to Basket
Live Chat Live Help Software for Website

Pipeline Insight: Cancer Overview – Breast and Gynecological Cancers

Datamonitor, Dec 2010


  Description  
   Table of Contents   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

The 'Pipeline Insight: Cancer Overview – Breast and Gynecological Cancers' report is due to be published in December 2010.

This report will cover the following key topics:

- Pipeline Overview and Dynamics
- Epidemiology
- Market overview
- R&D Approach
- Pipeline Analysis & Forecasts: Breast
- Pipeline Analysis & Forecasts: Ovarian
- Pipeline Analysis & Forecasts: Cervical
- Innovative Early-Stage Approaches

This report pack includes the Full report (pdf), Datapack (xls) and Executive presentation (ppt)



Customers who bought this item also bought

Pipeline Insight: Cancer Overview- Breast and Gynecological Cancers - Promising agents emerge for BRCA positive patients

Pipeline Insight: Lung Cancers Overview - Intensive R&D activity but little improvement in patient outcomes

Pipeline Insight: Cancer Overview Malignant Melanoma, Neuroendocrine Tumors and Thyroid Cancer - New drug approvals likely after decades of little progress

Pipeline and Commercial Insight: Neuropathic Pain - Pipeline setbacks prolong Pfizer's supremacy

Pipeline Insight: Moderate-to-Severe Acute Pain - Positive outlook for opioid-sparing analgesics

Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic gastrointestinal cancers represent a significant commercial opportunity due to a lack of approved drugs

Pipeline Insight: Small Molecule Targeted Cancer Therapies - New targets set to drive growth

Antibody-Drug Conjugates 2011 - real breakthrough still to come. A Technology, Stakeholder and R&D Pipeline Analysis

Competitor Analysis: Antibody-Drug Conjugates (ADC) 2010 Update

Pipeline Insight: Osteoporosis - Bone building drugs become the heart of the pipeline



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds